JP2007295926A5 - - Google Patents

Download PDF

Info

Publication number
JP2007295926A5
JP2007295926A5 JP2007078649A JP2007078649A JP2007295926A5 JP 2007295926 A5 JP2007295926 A5 JP 2007295926A5 JP 2007078649 A JP2007078649 A JP 2007078649A JP 2007078649 A JP2007078649 A JP 2007078649A JP 2007295926 A5 JP2007295926 A5 JP 2007295926A5
Authority
JP
Japan
Prior art keywords
gpvi
antibody
platelet membrane
variant
membrane glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007078649A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007295926A (ja
JP5224707B2 (ja
Filing date
Publication date
Priority claimed from PCT/JP2006/301818 external-priority patent/WO2006117910A1/ja
Application filed filed Critical
Priority to JP2007078649A priority Critical patent/JP5224707B2/ja
Priority claimed from JP2007078649A external-priority patent/JP5224707B2/ja
Publication of JP2007295926A publication Critical patent/JP2007295926A/ja
Publication of JP2007295926A5 publication Critical patent/JP2007295926A5/ja
Application granted granted Critical
Publication of JP5224707B2 publication Critical patent/JP5224707B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2007078649A 2005-04-28 2007-03-26 抗血小板膜糖蛋白質ｖｉモノクローナル抗体 Expired - Fee Related JP5224707B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007078649A JP5224707B2 (ja) 2005-04-28 2007-03-26 抗血小板膜糖蛋白質ｖｉモノクローナル抗体

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2005132665 2005-04-28
JP2005132665 2005-04-28
JP2005348534 2005-12-01
JP2005348534 2005-12-01
JPPCT/JP2006/301818 2006-01-27
PCT/JP2006/301818 WO2006117910A1 (ja) 2005-04-28 2006-01-27 抗血小板膜糖蛋白質ⅵモノクローナル抗体
JP2007078649A JP5224707B2 (ja) 2005-04-28 2007-03-26 抗血小板膜糖蛋白質ｖｉモノクローナル抗体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007514878A Division JP4185555B2 (ja) 2005-04-28 2006-04-28 抗血小板膜糖蛋白質ｖｉモノクローナル抗体

Publications (3)

Publication Number Publication Date
JP2007295926A JP2007295926A (ja) 2007-11-15
JP2007295926A5 true JP2007295926A5 (ru) 2011-05-19
JP5224707B2 JP5224707B2 (ja) 2013-07-03

Family

ID=38765971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007078649A Expired - Fee Related JP5224707B2 (ja) 2005-04-28 2007-03-26 抗血小板膜糖蛋白質ｖｉモノクローナル抗体

Country Status (1)

Country Link
JP (1) JP5224707B2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009284771A (ja) * 2008-05-27 2009-12-10 Takara Bio Inc 抗体産生細胞の作製方法
ES2596254T3 (es) * 2009-12-18 2017-01-05 Sanofi Novedosos anticuerpos antagonistas y sus fragmentos Fab contra GPVI y usos de los mismos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2706547T3 (es) * 1998-12-23 2019-03-29 Pfizer Anticuerpos monoclonales humanos para CTLA-4
KR100453877B1 (ko) * 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
WO2004039826A1 (en) * 2001-11-14 2004-05-13 Centocor, Inc. Anti-il-6 antibodies, compositions, methods and uses
EP1369128A1 (en) * 2002-06-07 2003-12-10 Procorde GmbH Inhibitors of glycoprotein VI and their therapeutic use
KR100932340B1 (ko) * 2002-10-17 2009-12-16 젠맵 에이/에스 Ｃｄ20에 대한 인간 모노클로날 항체
MXPA05013141A (es) * 2003-06-09 2006-03-17 Wyeth Corp Metodo mejorado para la recuperacion de arn virus de cadena negativa, no segmentados, a partir de adnc.
EP1656392A2 (en) * 2003-08-12 2006-05-17 Dyax Corp. Tie1-binding ligands

Similar Documents

Publication Publication Date Title
JP2005120106A5 (ru)
JP2010273685A5 (ru)
JP2017160222A5 (ru)
CN105073196B (zh) 呼吸道合胞病毒f蛋白表位
Burnett et al. Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
RU2012122173A (ru) Варианты альбумина
JP2018033454A5 (ru)
CN106413749B (zh) 新颖全谱抗登革抗体
JP2010531136A5 (ru)
JP2009261399A5 (ru)
JP2014518883A5 (ru)
RU2016106583A (ru) Пептиды, способные реактивировать мутанты р53
JP2009505964A5 (ru)
JP2012507994A5 (ru)
Pulido et al. Crystal structure of the heterotrimeric integrin-binding region of laminin-111
JP2020515248A5 (ru)
EP3992205A1 (en) Sars coronavirus-2 spike protein binding compounds
RU2016152429A (ru) Меченый антиген е гепаднавируса и его применение в скрининге противовирусных веществ
JP2007295926A5 (ru)
JP2010279373A5 (ru)
ES2605471T3 (es) Variantes de CRIg de afinidad madurada
JP2013502217A5 (ru)
JP2015536347A5 (ru)
JP2008515390A5 (ru)
JP2003514549A5 (ru)